At jMedtech, the mission is clear—enhance patient safety and elevate medical device performance through cutting-edge solutions. Since 2013, our focus has been on creating advanced technologies that redefine industry standards. One of our proudest innovations is jHemo PC® Phosphorylcholine Hemocompatible Coating, designed to deliver exceptional hemocompatibility and long-term effectiveness. As specialists in medical device coating, we continually push the boundaries to meet the evolving needs of healthcare professionals and patients worldwide.
Developing a coating that truly improves patient outcomes requires more than just technology—it requires an understanding of biology at the molecular level. Our jHemo PC® coating leverages phosphorylcholine (PC), a key component found on the outer layer of non-activated cell membranes. This unique amphiphilic phospholipid resists both protein and cell adhesion, making it the ideal material for reducing thrombosis risks in vascular devices.
By covalently bonding PC to the surface of a medical device, we create a stable and long-lasting hemocompatible layer. This layer acts as a biological “non-stick” shield, minimizing protein aggregation and reducing clot formation. The water molecules surrounding the PC-based surface provide an extra layer of protection, ensuring consistent anti-adhesive and anti-crystallization properties.
For us, medical device coating is not just about adding a layer—it’s about creating a solution that aligns with the body’s natural processes. This approach ensures better outcomes for patients and confidence for healthcare providers.
When we talk about innovative coatings for the medical industry, it’s not just a tagline—it’s a promise. Our antithrombogenic coating has been successfully integrated into 11 different product categories, including stent grafts, vascular grafts, neurological guidewires, haemodialysis catheters, heart valves, and many more. Each application reinforces our expertise in delivering solutions that enhance device performance and patient safety.
The benefits of our jHemo PC® coating extend far beyond clot prevention. It significantly reduces biofilm formation, lowering the risk of infection, and its nanometer-level thickness ensures precision without compromising device flexibility. With durability and long-lasting effectiveness, this coating delivers consistent performance under real-world clinical conditions.
As a company dedicated to progress, we understand the importance of staying ahead in technology and research. That’s why every development, including our hemocompatible coating, undergoes rigorous testing and quality assurance within our ISO13485-certified facilities. Our commitment ensures that medical device manufacturers receive not just a coating but a performance-enhancing solution.
At jMedtech, innovation is more than a goal—it’s our responsibility. Through jHemo PC® and our other groundbreaking technologies, we continue to lead in medical device coating solutions that prioritize safety, reliability, and clinical success. By delivering innovative coatings for the medical industry, we aim to support healthcare providers in achieving better patient outcomes and shaping a safer, more advanced future in medical care.
